missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ZEB1 Antibody (2A8H3) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Marca: Novus Biologicals NBP2-37329-0.025ml
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
ZEB1 Monoclonal specifically detects ZEB1 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, CyTOF-ready.
Specifica
| ZEB1 | |
| Monoclonal | |
| 1 mg/mL | |
| Western Blot 1:500 - 1:2000, Flow Cytometry 1:200 - 1:400, ELISA 1:10000, Immunohistochemistry 1:200 - 1:1000, Immunocytochemistry/Immunofluorescence 1:200 - 1:1000, Immunohistochemistry-Paraffin 1:200 - 1:1000, CyTOF-ready | |
| AREB6MGC133261, delta-crystallin enhancer binding factor 1, DELTAEF1, FECD6, Negative regulator of IL2, NIL2A, NIL-2-A, NIL-2-A zinc finger protein, posterior polymorphous corneal dystrophy 3, PPCD3, TCF-8, TCF8BZP, Transcription factor 8, transcription factor 8 (represses interleukin 2 expression), ZEB, Zfhep, ZFHX1A, zinc finger E-box binding homeobox 1, zinc finger E-box-binding homeobox 1, zinc finger homeodomain enhancer-binding protein | |
| Mouse | |
| 124 kDa | |
| 0.025 mL | |
| Cancer, Chromatin Research, Immunology, Neuroscience, Signal Transduction, Transcription Factors and Regulators, Vision, Zinc Finger | |
| 6935 | |
| Store at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles. |
| Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| 2A8H3 | |
| Unconjugated | |
| PBS with 0.05% Sodium Azide | |
| ZEB1 | |
| Purified recombinant fragment of human ZEB1 (AA: 967-1108) expressed in E. Coli. | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Human | |
| IgG1 |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
For Research Use Only
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto